Recurrence of Primary Breast Lymphoma Presenting as Bilateral Vitreoretinal Lymphoma.

IF 0.9 Q4 OPHTHALMOLOGY Ocular Oncology and Pathology Pub Date : 2021-10-01 Epub Date: 2021-05-19 DOI:10.1159/000515560
Karishma Habbu, Roshan George, Miguel Materin
{"title":"Recurrence of Primary Breast Lymphoma Presenting as Bilateral Vitreoretinal Lymphoma.","authors":"Karishma Habbu,&nbsp;Roshan George,&nbsp;Miguel Materin","doi":"10.1159/000515560","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This report describes a case of relapsed primary breast lymphoma (PBL) presenting as vitreoretinal lymphoma (VRL).</p><p><strong>Methods: </strong>We describe the clinical and hematopathologic findings in a patient with relapsed PBL involving the vitreous of both eyes.</p><p><strong>Results: </strong>A 59-year-old woman was treated for PBL with systemic and intrathecal chemotherapy 5 years prior to presentation. Three years later, she presented to an outside clinic with blurred vision in both eyes and bilateral vitritis. She was referred to our clinic with concern for ocular lymphoma. On presentation, the patient's best-corrected visual acuity was 20/40 in the right eye and 20/25 in the left eye with 3+ vitreous cells in the right eye and 2+ vitreous cells in the left eye. Vitreous biopsy of the right eye revealed CD5-negative/CD10-negative B-cell lymphoma cells on flow cytometry. She had no evidence of disease on brain MRI, lumbar puncture, bone marrow biopsy, or full-body CT scans. She was treated with a regimen of rituximab, methotrexate, procarbazine, and vincristine for central nervous system penetration as well as multiple intraocular injections of methotrexate and rituximab with improvement in vision and ocular inflammation bilaterally.</p><p><strong>Conclusion: </strong>Relapsed PBL can present as bilateral VRL.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000515560","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Oncology and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000515560","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/5/19 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This report describes a case of relapsed primary breast lymphoma (PBL) presenting as vitreoretinal lymphoma (VRL).

Methods: We describe the clinical and hematopathologic findings in a patient with relapsed PBL involving the vitreous of both eyes.

Results: A 59-year-old woman was treated for PBL with systemic and intrathecal chemotherapy 5 years prior to presentation. Three years later, she presented to an outside clinic with blurred vision in both eyes and bilateral vitritis. She was referred to our clinic with concern for ocular lymphoma. On presentation, the patient's best-corrected visual acuity was 20/40 in the right eye and 20/25 in the left eye with 3+ vitreous cells in the right eye and 2+ vitreous cells in the left eye. Vitreous biopsy of the right eye revealed CD5-negative/CD10-negative B-cell lymphoma cells on flow cytometry. She had no evidence of disease on brain MRI, lumbar puncture, bone marrow biopsy, or full-body CT scans. She was treated with a regimen of rituximab, methotrexate, procarbazine, and vincristine for central nervous system penetration as well as multiple intraocular injections of methotrexate and rituximab with improvement in vision and ocular inflammation bilaterally.

Conclusion: Relapsed PBL can present as bilateral VRL.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
原发性乳腺淋巴瘤复发表现为双侧玻璃体视网膜淋巴瘤。
目的:本报告报告一例复发性原发性乳腺淋巴瘤(PBL),表现为玻璃体视网膜淋巴瘤(VRL)。方法:我们描述了一个复发性PBL累及双眼玻璃体的患者的临床和血液病理学表现。结果:一名59岁的女性在发病前5年接受了全身和鞘内化疗。三年后,她以双眼视力模糊和双侧玻璃体炎就诊于门诊。她因眼部淋巴瘤被转介到我们诊所。患者就诊时,最佳矫正视力为右眼20/40,左眼20/25,右眼3+玻璃体细胞,左眼2+玻璃体细胞。右眼玻璃体活检显示cd5阴性/ cd10阴性b细胞淋巴瘤细胞。颅脑MRI、腰椎穿刺、骨髓活检或全身CT扫描均未发现病变。患者接受利妥昔单抗、甲氨蝶呤、丙卡嗪和新碱治疗,用于穿透中枢神经系统,并多次眼内注射甲氨蝶呤和利妥昔单抗,双侧视力和眼部炎症均有改善。结论:复发性PBL可表现为双侧VRL。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
20
期刊最新文献
Description and Characteristics of Ocular Tumor Lysis Syndrome. How Much Time Do Focal Treatments for Retinoblastoma Add to Anesthetic Exposure? Ruthenium-106 Plaque Brachytherapy for Circumscribed Choroidal Hemangioma: A Case Series and Review of Literature. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Clinicopathologic Features of Eyelid Sebaceous Gland Carcinoma Requiring Immunohistochemical Diagnosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1